Zobrazeno 1 - 10
of 48
pro vyhledávání: '"O V, Kniazev"'
Autor:
L M Krums, A F Babaian, S V Bykova, A A Lishchinskaia, S G Khomeriki, R B Gudkova, E A Sabel'nikova, O V Kniazev, A I Parfenov
Publikováno v:
Терапевтический архив, Vol 91, Iss 2, Pp 87-90 (2019)
The article provides clinical observation of a patient who was diagnosed with celiac disease when he was 52 years (Marsh stage IIIB). Following gluten-free diet (GFD) clinical remission and restoration of small intestinal mucosa (SIM) structure occur
Externí odkaz:
https://doaj.org/article/dddfcd3bcee544d19becee1bcdf42b98
Autor:
O V Kniazev, A I Parfenov, A G Konopliannikov, I N Ruchkina, A A Churikova, S V Bykova, E A Albulova, O N Boldyreva, N A Fadeeva, A A Lishchinskaia
Publikováno v:
Терапевтический архив, Vol 87, Iss 2, Pp 39-44 (2015)
Aim. To compare the safety of therapy in patients with ulcerative colitis (UC) and Crohn's disease (CD) who have received combination anti-inflammatory therapy using bone marrow mesenchymal stromal cells (MSC) and standard therapy with 5-aminosalicyl
Externí odkaz:
https://doaj.org/article/f079545ef0244687b7988f936e1aca3b
Autor:
A I Parfenov, O N Boldyreva, I N Ruchkina, O V Kniazev, V É Sagynbaeva, P L Shcherbakov, S G Khomeriki, L B Lazebnik, A G Konopliannikov
Publikováno v:
Терапевтический архив, Vol 86, Iss 2, Pp 32-38 (2014)
AIM: To define the value of adhesion molecules (sVCAM-1 integrin, P-selectin, E-selectin, and L-selectin) for the prediction and evaluation of the efficiency of treatment in patients with ulcerative colitis (UC) and Crohn's disease/MATERIAL AND METHO
Externí odkaz:
https://doaj.org/article/4750231d7d85479dae179af19c34ea82
Autor:
O V Kniazev, A I Parfenov, P L Shcherbakov, A G Konopliannikov, I N Ruchkina, A A Lishchinskaia
Publikováno v:
Терапевтический архив, Vol 86, Iss 2, Pp 102-105 (2014)
Perianal fistulas are the most common and frequently encountered types of fistulas in Crohn's disease (CD). They are incurable, may worsen quality of life in a patient and increase the risk of total bowel resection. Despite the significant impact of
Externí odkaz:
https://doaj.org/article/25017bfac7e2403d93aa6937dd50a4bf
Publikováno v:
Терапевтический архив, Vol 85, Iss 12, Pp 55-59 (2013)
AIM: To study biological (cell and anticytokine) therapy-induced changes in the levels of proinflammatory cytokines in patients with inflammatory bowel diseases (IBD)/MATERIAL AND METHODS: Forty-four patients with chronic continuous or chronic recurr
Externí odkaz:
https://doaj.org/article/d7dbdaf2ac264becbe16a2dd2173cb4b
Autor:
O V Kniazev, A I Parfenov, I N Ruchkina, A G Konopliannikov, V N Drozdov, V É Sagynbaeva, T I Ivkina
Publikováno v:
Терапевтический архив, Vol 85, Iss 2, Pp 57-60 (2013)
A search for ways to overcome the secondary inefficiency of anti-cytokine therapy (ACT) with infliximab (IFX) in patients with inflammatory bowel diseases (IBD) remains relevant and determines the need for new approaches to solving this problem. The
Externí odkaz:
https://doaj.org/article/ae2d35737f724dc18e35478175aabd96
Autor:
O V Kniazev, L B Lazebnik, A I Parfenov, I N Ruchkina, P L Shcherbakov, A G Konopliannikov, Z F Mikhaĭlova, S G Khomeriki
Publikováno v:
Терапевтический архив, Vol 84, Iss 12, Pp 103-107 (2012)
Cytomegalovirus (CMV) is one of the common pathogens of opportunistic infections in patients with inflammatory bowel diseases. When the patients are treated with immunosuppressants that make them more susceptible to CMV, the course of ulcerative coli
Externí odkaz:
https://doaj.org/article/62bedfd159334edf92c8bbcf6b8d4f89
Autor:
L B Lazebnik, O V Kniazev, A I Parfenov, I N Ruchkina, P L Shcherbakov, S G Khomeriki, A G Konopliannikov
Publikováno v:
Терапевтический архив, Vol 84, Iss 8, Pp 10-17 (2012)
Aim. To elaborate optimal cell culture administration regimens to enhance the efficiency of anti-inflammatory therapy for inflammatory bowel diseases. Subjects and methods. Three groups of patients with chronic continuous or chronic recurrent ulcerat
Externí odkaz:
https://doaj.org/article/ca2a5774a5214236b345162179a53637
Publikováno v:
Eksperimental'naia i klinicheskaia gastroenterologiia = Experimentalclinical gastroenterology. (8)
Among the chronic diseases of the gastrointestinal tract of the special place occupied by inflammatory bowel disease (IBD), in which the lining of the intestine produces a significant number of neutrophils, which has prompted researchers and clinicia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b1ba2a84ac3c1cd67449990aff1aa2cc
https://pubmed.ncbi.nlm.nih.gov/24933942
https://pubmed.ncbi.nlm.nih.gov/24933942
Publikováno v:
Terapevticheskii arkhiv. 85(12)
To study biological (cell and anticytokine) therapy-induced changes in the levels of proinflammatory cytokines in patients with inflammatory bowel diseases (IBD).Forty-four patients with chronic continuous or chronic recurrent IBD were examined. Acco
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::0697230599834e0c74ad711285760087
https://pubmed.ncbi.nlm.nih.gov/24640669
https://pubmed.ncbi.nlm.nih.gov/24640669